WIM INVESTMENT MANAGEMENT Ltd Makes New $375,000 Investment in Grail, Inc. (NASDAQ:GRAL)

WIM INVESTMENT MANAGEMENT Ltd acquired a new position in shares of Grail, Inc. (NASDAQ:GRAL) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 21,000 shares of the company’s stock, valued at approximately $375,000. Grail accounts for about 0.1% of WIM INVESTMENT MANAGEMENT Ltd’s holdings, making the stock its 15th largest holding. WIM INVESTMENT MANAGEMENT Ltd owned 0.06% of Grail at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. Crcm LP acquired a new position in Grail during the 4th quarter valued at $65,061,000. Primecap Management Co. CA acquired a new position in shares of Grail in the 4th quarter valued at $37,118,000. Bank of New York Mellon Corp acquired a new position in shares of Grail in the 4th quarter valued at $6,262,000. TCW Group Inc. acquired a new position in shares of Grail in the 4th quarter valued at $5,095,000. Finally, abrdn plc acquired a new position in shares of Grail in the 4th quarter valued at $3,768,000.

Insiders Place Their Bets

In other Grail news, CFO Aaron Freidin sold 1,816 shares of the stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $56,659.20. Following the sale, the chief financial officer now owns 335,170 shares of the company’s stock, valued at $10,457,304. This represents a 0.54 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Robert P. Ragusa sold 7,625 shares of the stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.21, for a total transaction of $237,976.25. Following the sale, the chief executive officer now directly owns 828,662 shares in the company, valued at approximately $25,862,541.02. This represents a 0.91 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,550 shares of company stock valued at $360,436 in the last 90 days.

Grail Trading Down 3.3 %

Shares of Grail stock opened at $28.18 on Wednesday. The company has a 50-day simple moving average of $32.20 and a 200 day simple moving average of $21.59. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99.

Grail (NASDAQ:GRAL) last announced its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($4.41) by $2.55. The firm had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. On average, analysts predict that Grail, Inc. will post -15.15 EPS for the current year.

Analyst Ratings Changes

Separately, Morgan Stanley increased their price objective on shares of Grail from $16.00 to $20.00 and gave the company an “equal weight” rating in a research note on Tuesday.

Grail Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.